Buzzing Stocks: Prestige Estates falls as subsidiary withdraws DRHP; Zydus Life hits 52-week high on zero…

According to fresh market updates, Stock-specific activity is likely to stay in focus on Dalal Street on September 28, following a slew of corporate developments, and earnings.

Unichem Laboratories stock price shed 1% after US Food and Drug Administration (USFDA) conducted an inspection at the firm's Goa formulation facility in Pilerne from September 21 to 26, 2026. The inspection concluded with five observations related to procedural enhancements.

Zydus Lifesciences stock price touched 52-week high after the US Food and Drug Administration (USFDA) conducted an on-site inspection of the firm's pharmacovigilance and post-marketing surveillance systems at its office in New Jersey, US, from September 22 to 25, 2026. The inspection concluded with nil observations.

Wheels India stock price advanced 1% after the firm closed its qualified institutional placement (QIP) offering on September 25 and approved the allotment of 11.97 lakh shares at Rs 2,088 per share. The offering price was at a discount of Rs 109.10 per share to the floor price of Rs 2,197.10 per share. Aditya Birla Sun Life AMC, SBI Mutual Fund, WhiteOak Capital and Ashoka India Equity Investment Trust Plc were among the market participants in the QIP.

Aequs stock price rose 1% after the firm's board approved the preferential offering of up to 2.8 crore warrants to Mellwood Trustee Services, a member of the promoter group, aggregating to approximately Rs 650 crore. Of the total offering size, Rs 325 crore will be payable upfront upon allotment, with the balance payable upon exercise of the warrants.

Prestige Estates Projects stock price lost 1.5% after its subsidiary, Prestige Hospitality Ventures (PHVL), decided to withdraw its draft red herring prospectus (DRHP), citing strategic considerations and uncertain market conditions. PHVL may consider filing a fresh DRHP with SEBI in the future for an initial public offering of its equity shares.

Market participants are anticipated to stay focused on brokerage calls, block deals, order wins, regulatory developments and other firm-specific triggers that could drive stock-level volatility during the session.